Next 10 |
Environmental Impact Acquisition Corporation approval obtained; GreenLight Biosciences set to begin trading under Nasdaq: GRNA on February 3, 2022 PR Newswire BOSTON , Feb. 2, 2022 /PRNewswire/ -- Environmental Impact Acquisition Corporation (NASDAQ: ENVI), a pub...
GreenLight Biosciences and Germains Seed Technology Partner to Explore Development of World's First dsRNA Seed Treatment to Control Pests PR Newswire BOSTON , Jan. 31, 2022 /PRNewswire/ -- GreenLight Biosciences and Germains Seed Technology , an industry ...
ENVI Announces Quorum to Pass Business Combination With GreenLight Biosciences and Achievement of All Transaction Requirements Following the Redemption Deadline Upon consummation of the business combination, the ENVI ticker will transition to "GRNA" and is expected to start trad...
ENVI and GreenLight Biosciences Announce Filing of Definitive Proxy Statement/Prospectus and the February 1st, 2022 Special Meeting to Approve Proposed Business Combination PR Newswire BOSTON , Jan. 14, 2022 /PRNewswire/ -- Environmental Impact Acquisition Corpor...
GreenLight Biosciences (ENVI) partners with IAVI to accelerate COVID-19 vaccine trial in Africa - IAVI's extensive clinical trial experience will be combined with GreenLight COVID-19 vaccine candidate. - Goal is to broaden and accelerate access to messenger RNA (mRNA) COVID-...
Samsung Biologics has agreed to manufacture GreenLight Biosciences' (NASDAQ:ENVI) mRNA COVID-19 vaccine candidate at commercial scale. The companies say the arrangement aims to accelerate production of vaccine for phase 3 trials. GreenLight went public earlier this year in a combination with ...
Serum Life Sciences invests in RNA biotech GreenLight by joining expanded financing for Environmental Impact Acquisition Corp. PR Newswire BOSTON , Nov. 23, 2021 /PRNewswire/ -- GreenLight Biosciences Inc., an RNA-focused biotech ("GreenLight"), and Environm...
Greenlight Biosciences (ENVI) Adds Two World-Renowned Scientists To Its Scientific Advisory Board PR Newswire BOSTON , Nov. 4, 2021 /PRNewswire/ -- GreenLight Biosciences is delighted to announce the appointment of Professor Diane E. Griffin , MD, PhD, a...
GreenLight Biosciences opens RNA production facility for the next generation of agricultural products PR Newswire ROCHESTER, N.Y. , Sept. 22, 2021 /PRNewswire/ -- GreenLight Biosciences, Inc., a biotechnology company focused on RNA research, design, and...
Two rumored deals materialize at very large premiums. In a battle of railroads, Canadian Pacific comes back but gets rejected by Kansas City Southern. SPACs fire up with 17 new IPOs filed just last week. For further details see: Merger Arbitrage Mondays - BAMR Acquires A...
News, Short Squeeze, Breakout and More Instantly...
Environmental Impact Acquisition Corporation approval obtained; GreenLight Biosciences set to begin trading under Nasdaq: GRNA on February 3, 2022 PR Newswire BOSTON , Feb. 2, 2022 /PRNewswire/ -- Environmental Impact Acquisition Corporation (NASDAQ: ENVI), a pub...
GreenLight Biosciences and Germains Seed Technology Partner to Explore Development of World's First dsRNA Seed Treatment to Control Pests PR Newswire BOSTON , Jan. 31, 2022 /PRNewswire/ -- GreenLight Biosciences and Germains Seed Technology , an industry ...
ENVI Announces Quorum to Pass Business Combination With GreenLight Biosciences and Achievement of All Transaction Requirements Following the Redemption Deadline Upon consummation of the business combination, the ENVI ticker will transition to "GRNA" and is expected to start trad...